Skip to main content
| News

New innovation campus opens in the Basel Area

29.10.2022

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal Councillor Guy Parmelin highlighted the leading position of this life science cluster in the country as well as on a European and global level.

Federal Councillor Guy Parmelin pushes the buzzer to open officially the Switzerland Innovation Park Basel Area Main Campus (img: Mathias Mangold)

On Saturday October 29, Federal Councillor Guy Parmelin formally opened the Main Campus of the Switzerland Innovation Park Basel Area on schedule. Around 200 guests attended the official opening ceremony of Switzerland’s most modern innovation park, which is located in the Bachgraben area of Allschwil in the canton of Basel-Landschaft. The three supporting cantons of the Switzerland Innovation Park Basel Area were represented by cantonal ministers Thomas Weber (Basel-Landschaft), Kaspar Sutter (Basel-Stadt), and Jacques Gerber (Jura).

According to a press release, Parmelin stated in his opening speech: “The Basel Area life science cluster is not only of vital importance for the Swiss economy, but it also occupies a leading position in Europe and the world.” He is convinced that the innovation park will “further enhance the region’s importance”. Raymond Cron, CEO of Switzerland Innovation, expressed his desire that the new innovation campus establish itself as an international beacon for innovative projects in the field of health and life sciences in Switzerland.

Designed by architects Herzog & de Meuron

Spanning 50,000 square meters, the cluster provides workplaces for around 2,000 individuals. The building was designed by the Basel-based architects Herzog & De Meuron. The plans were realized by the building contractor Senn Resources.

According to the information provided, approximately 70 percent of the laboratory and office space in the main campus is currently being rented out to 38 companies and institutes. This includes the University of Basel, numerous startups, plus large companies such as Johnson & Johnson and Basilea. There are now four sites in the Switzerland Innovation Park Basel Area, which is being operated by the investment and innovation promotion agency Basel Area Business & Innovation. It is one of six innovation parks in the Switzerland Innovation foundation’s national network.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.